Several lines of studies in other cancer types have demonstrated an impact of REG4 on tumor growth, invasion, metastasis, and resistance to apoptosis [20], [46], [47], which is similar to the role of ADAM9 in prostate cancer seen in the previous and the present studies. Here, REG4 is linked to prostate carcinoma.